Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in MEN1-associated primary hyperparathyroidism
NL-OMON34871Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in primary hyperparathyroidism (PHPT), sponsored by Leiden University Medical Center. Primary endpoints: Clinical parameters, Biochemical parameters and 2 more. Started Jul 2010; status: active, not recruiting.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NL-OMON34871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34871.